NEW HCPCS code C1849 – Skin substitute, synthetic, resorbable per square centimeter

On July 1, 2020, the Centers for Medicare & Medicaid Services (CMS) established a new Healthcare Common Procedural Coding System (HCPCS) code C1849 synthetic, resorbable, skin substitutes, which is applicable in ASCs where it is assigned to the high-cost skin substitute package. The CMS has confirmed that C1849 is applicable to Microlyte® Matrix.

Below are links to our reimbursement overview and guide for both Hospital-Owned Outpatient Provider-Based Department (PBD) and Ambulatory Surgery Center (ASC) places of service.

PBD Overview
ASC Overview

For Reimbursement questions, please submit your inquiry using the form below:

  • Type of Reimbursement

  • (Please do not submit patient information)

Information on reimbursement in the U.S. is provided by Imbed Biosciences as a courtesy. Medicare payment policy and related law can change rapidly, and the information provided herein does not constitute a guarantee or warranty that reimbursement will be received or that the codes identified herein are or will remain applicable. This information is provided “AS IS” and without any other warranty or guarantee, expressed or implied, as to completeness or accuracy, or otherwise. The information presented herein is based on data gathered from many primary and secondary sources, including the American Medical Association and certain Medicare contractors. Each payer may have different coding and coverage policies or decisions, therefore providers must confirm or clarify coding and coverage from their respective payers. Providers are responsible for accurate documentation of patient conditions and for reporting of products in accordance with particular payer requirements.

Get news and information about Microlyte® Matrix